Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy

BACKGROUND: Systemic inflammation may be involved in the entire cancer process as a promoter and is associated with antitumor immunity. The systemic immune-inflammation index (SII) has been shown to be a promising prognostic factor. However, the relationship between SII and tumor-infiltrating lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jun, Zheng, Jifang, Qiu, Jianjian, Zhang, Mengyan, Liu, Lingyun, Wang, Zhiping, Zheng, Qunhao, Liu, Yanyan, Chen, Mingqiu, Li, Jiancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205413/
https://www.ncbi.nlm.nih.gov/pubmed/37228442
http://dx.doi.org/10.1155/2023/4275998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205413/
https://www.ncbi.nlm.nih.gov/pubmed/37228442
http://dx.doi.org/10.1155/2023/4275998

Ejemplares similares